CTLA4 and osteosarcoma: CTLA-4 (cytotoxic T-lymphocyte antigen-4) is a glycoprotein co-inhibitory receptor involved in T-cell activation, which is expressed in osteosarcoma cells, among other types of malignancies [37, 38].